Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study (Q70363398)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

J Levy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

A L Smith

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

J R Koup

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

J Williams-Warren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

B Ramsey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

language of work or name

English

0 references

publication date

1 July 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

10 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

117-124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis

10 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Tobramycin therapy of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis: effect of dosage and concentration of antibiotic in sputum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Why Monitor Serum Levels of Gentamicin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Aminoglycoside clearance in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

The pharmacokinetics of amikacin in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Pharmacokinetics of netilmicin in children with and without cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Pharmacokinetics of tobramycin in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

A new prognostic score and clinical evaluation system for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Pharmacokinetics of Gentamicin in Children and Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Simultaneous measurement of glomerular filtration rate and renal plasma flow using plasma disappearance curves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Comparison of enzymatic and microbiological gentamicin assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

A pharmacokinetic analysis program (multi) for microcomputer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Computation of model-independent pharmacokinetic parameters during multiple dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Gentamicin binding to serum and plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Clinical Pharmacokinetics of Aminoglycoside Antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Autoradiographic Localization of [ 3 H]Gentamicin in the Proximal Renal Tubules of Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Gentamicin disposition and tissue accumulation on multiple dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Gentamicin tissue accumulation and nephrotoxic reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

The effect of frusemide and piretanide on the renal clearance of gentamicin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Concentrations of gentamicin and carbenicillin in bronchial secretions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Concentrations of Netilmicin in Bronchial Secretions and Serum during Intermittent vs. Continuous Infusion: A Crossover Study in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Gentamicin Levels in the Human Biliary Tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Predictability of peak serum gentamicin concentration with dosage based on body surface area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Two-compartment gentamicin pharmacokinetics in premature neonates: a comparison to adults with decreased glomerular filtration rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980375-3

10.1016/S0022-3476(84)80375-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6376743%20AND%20SRC:MED&resulttype=core&format=json